- NCIt
- C3629
Loading cancer entity…
Loading cancer entity…
Clinical trials
10 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02756754 | Radiofrequency Ablation for Aldosterone-producting Adenoma in Patients With Primary Aldosteronism(ADERADHTA) | completed | N/A | 31 | University Hospital, ToulouseOTHER | 1 | May 4, 2026 | clinicaltrials |
| NCT06576336 | A Randomized Clinical Trial About Use of 3D Laparoscopy Versus 2D Laparoscopy in Adrenal Surgery(3DAdrenal) | completed | Phase 4 | 350 | University of PalermoOTHER | 1 | Aug 28, 2024 | clinicaltrials |
| NCT02468193 | Study of Efficacy and Safety of Osilodrostat in Cushing's Syndrome | completed | Phase 2 | 9 | Novartis PharmaceuticalsINDUSTRY | 1 | May 6, 2020 | clinicaltrials |
| NCT03830593 |
Data updated 22 days agoSource updated May 4, 2026source: clinicaltrials
| completed |
| — |
| 102 |
| Samsun Liv HospitalOTHER |
| 1 |
| Oct 10, 2019 |
| clinicaltrials |
| NCT02150213 | Medical Safety Follow-up Study for Patients Who Received More Than 28 Days of Total Exposure to BGG492 | completed | Phase 2 | 59 | Novartis PharmaceuticalsINDUSTRY | 6 | Dec 5, 2016 | clinicaltrials |